Albumin-recruiting lipid nanoparticles could make future mRNA vaccines safer and more effective

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine technology that could make future vaccines safer, more effective, and less burdensome for patients.

Recent Posts

editors picks

Top Reviews